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ABSTRACT
Cardiovascular  disease  (CVD)  contributes  greatly  to  inequalities  in  health  in 
Europe. The CVD death rate in Ukraine (the highest) is seven fold higher than in 
France (the lowest). There is also a striking difference in CVD mortality between 
European Union (EU) members before the enlargement in 2004 and Central and 
East European (CEE) countries that joined the EU in 2004 and non-EU countries. 
The difference in CVD mortality between West and East Europe grew during the 
1970s and 1980s when rates declined in the West and either remained the same or 
rose in the CEE countries. Political reforms at the beginning of the 1990s, which 
were followed by great socio-economic changes coincided with further diversi-
fication in CVD mortality in CEE countries. Diverse trends in CVD mortality were 
followed by larger gaps in life expectancy between West and East Europe and 
within the CEE. 
Rapid development of high technology treatment procedures, which followed 
the economic recovery of the CEE countries, would have only limited influence on 
the overall control of CVD. Exposure to classic risk factors might largely explain 
the longitudinal trend in falling CVD mortality in some countries, but it is unlikely 
that it could explain rapid changes in the others. Still, large potential to control the 
disease  lies  in  developing  effective  preventive  policies  with  targets  to  lower 
exposure  to  the  classic  CVD  risk  factors. The  recent  history  of  CVD  in  CEE 
countries makes the “alcohol hypothesis” less convincing as an explanation for 
CVD mortality trends and differences between East and West Europe. The hypo-
thesis that dynamic changes in CVD mortality in CEE countries are triggered and 
explained  largely  by  psychosocial  factors  is  attractive.  However,  if  confirmed, 
transforming  such  knowledge  into  a  practical  health  policy  would  be  a  great 
challenge.
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INTRODUCTION
In  developed  countries,  diseases  of  the  heart  and  circulatory  system 
(cardiovascular disease or CVD) are the main cause of deaths, an important 
cause of disability and a source of large economic and social cost to the 
society. In the European Union (15 countries before 2004), Coronary Heart 
Disease (CHD) and brain stroke were the most frequent forms of CVD 
(about 37% and 25%, respectively). In the Central and East European 
(CEE) countries, CHD and stroke were responsible for 49 percent and 32 
percent of all CVD deaths, respectively.1 These differences suggest that 
CHD and stroke contribute largely to the East-West difference in CVD 
mortality and life expectancy gap. The knowledge of the nature of the 
disease, its prevention and treatment increased largely in recent decades but 
regional inequality due to CVD still remains one of the most important 
public health problems in Europe and worldwide. 
Fig. 1. Age-standardized CVD death rates (per 100.000) in European Union (27 
countries) and three Eastern European not EU countries (last available year).
Source: WHO Europe, European HFA Database, December 2011.3418 PublicHealthReviews,Vol.33,No2
In the period from the 1980s through the1990s, Europe experienced a 
large political transformation that ended with enlargement of the European 
Union (EU) from 15 to 27 countries. The area of the EU changed from 3,19 
to 4,23 million square kilometres and the population increased from 376 to 
495 million citizens.2 These changes were mainly the effect of the inclusion 
of CEE countries, for which the period just before and after inclusion was 
a time of large political, economic and social revolutionary changes. At the 
time  of  accession  to  the  EU  the  populations  of  CEE  countries  were 
characterized by worse health indicators than those of Western Europe, 
with a large life expectancy gap between the West and East of the continent. 
This paper will focus on the differences in CVD mortality trends between 
CEE countries and debate possible explanations.
Fig. 2. Men to women ratio of CVD death rates (per 100.000) in European Union 
(27 countries) and three Eastern European not EU countries (last available year).
Source: WHO Europe, European HFA Database, December 2011.3
Despite the increasing knowledge of the determinants of CVD, it is the 
major contributor to inequalities in health in Europe. Age standardized 
CVD mortality rates for 30 European countries are presented in Figure1 
(latest available data).3 The CVD mortality rate in Ukraine (the highest) is 
sevenfold  higher  than  in  France  (the  lowest).  There  is  also  a  striking 
difference in CVD mortality between the old EU15 countries (members 
before the enlargement in 2004), with the countries that joined the EU in CardiovascularDiseaseinCentralandEastEurope 419
2004 and non-EU countries. In Figure 2, the ratio of CVD death rate in men 
to CVD death rate in women is presented by country. CVD mortality in 
men is higher than in women in all European countries and in general CEE 
countries  have  high  men  to  women  ratios.  However,  between  country 
differences in the gender mortality gap do not give a satisfactory explanation 
of the East-West CVD mortality gap. For example, Romania, with one of 
the highest CVD death rates, has one of the lowest men to women ratios. 
Also Ukraine, with the highest CVD death rate, has the men to women ratio 
closest to the mean. In contrast, Finland—an EU15 member, in which the 
CVD death rate is much lower than in CEE countries, the men to women 
ratio remains one of the highest. 
Fig. 3. Age-standardized CVD death rates (per 100.000) in six Central and Eastern 
European Countries and European Union (15 countries before May 2004).
Source: WHO Europe, European HFA Database, December 2011.3
Similar to West Europe, in CEE countries between-sex differences in 
CVD mortality were not combined with the differences in secular changes 
in the death rates, and trends in CVD mortality and in life expectancy were 
similar in men and in women. In Figure 3, trends in age standardized CVD 
death rates for the total population of six CEE countries are compared with 
the trends in the EU15 countries. In the early 1970s, differences in CVD 
mortality between West and East Europe were much smaller. Soon after 
CVD mortality started to decline in the West and the falling trend continues 
until today, meanwhile unchanged or rising rates were observed in the CEE 
countries. In the early 1990s, CVD mortality trends reversed in some East 
European countries (i.e., Poland, Hungary and Czech Republic), but an 
unprecedented, steep increase was observed in the others, mainly former 
Soviet Union countries. These increases halted after three years and CVD 420 PublicHealthReviews,Vol.33,No2
mortality also began to decline in the former Soviet Union countries. After 
1998, CVD mortality started to increase again in some former Soviet Union 
countries (e.g., Russia and Ukraine) and continued to decrease in others 
(e.g., Baltic countries). In both Russia and Ukraine, the trends reversed in 
2004 and continue to fall until the present (Figure 3). Changes in CVD 
mortality were followed by growing life expectancy gaps between EU and 
non-EU  countries,  between  EU-CEE  countries  and  other  western  EU 
countries,  and  between  former  Soviet  Union  Baltic  countries  that  now 
belong to the EU and other EU-CEE countries (Figure 4). Understanding 
determinants of these trends in CVD and explaining the differences in CVD 
mortality would contribute largely to CVD prevention strategies and health 
policy in Europe. 
Fig. 4. Life expectancy at age 45 in six Central and Eastern European Countries and 
European Union (15 countries before May 2004).
Source: WHO Europe, European HFA Database, December 2011.3
MEDICAL TREATMENT
The 1982-1994 WHO MONICA (Multinational MONItoring of trends and 
determinants of CArdiovascular disease) Project collected information on 
CHD mortality and incidence from within 37 well-defined populations 
from 21 countries. The findings showed that changes in case fatality rates 
contributed to 21 percent of the average change in CHD mortality in men 
and to 35 percent of change in women.4 Findings of the WHO MONICA 
Project did not clarify to what extent changes in case fatality could be 
related to the improvement of treatment and to preventive measures that CardiovascularDiseaseinCentralandEastEurope 421
affected the natural course of the disease. Nevertheless, introduction of 
revascularization procedures and the increase in the use of effective cardio-
protective drugs is seriously considered as one of the main causes of the 
decrease in CHD mortality and increase of life expectancy in some medical 
societies and in the United States is considered as one of the great public 
health achievements in the 20th century.5,6 
Around 1995, CEE countries were at the bottom of the scale in the use 
of  coronary  angiography.  For  example,  in  Poland  the  number  of 
examinations per one million population was nearly ten times lower than in 
the top country in Europe (Iceland).7 In Poland the reaction was fast and 
impressive. Large investments in the field of invasive cardiology resulted in 
the opening of over 100 new catheterization laboratories dispersed around 
the country, which resulted in a steep increase in the number of coronary 
angiographies and Percuteneous Coronary Interventions (PCIs) performed 
per  year  over  the  next  decade.  This  tremendous  effort  contributed  to 
improved care in the acute phase of CHD events but could not explain the 
dynamic decline in CVD mortality as the main decline occurred earlier - 
between 1991 and 1996. Further, the effectiveness of the treatment in an 
acute event is dependent upon the time of its application. The earlier it 
takes place, the better effect can be expected. Some studies from Poland 
confirmed that frequently treatments are not applied in the recommended 
time period after the onset of an event and that the main delay is due to the 
late call for medical service.8,9 
Recent findings of the project IMPACT Poland confirmed that change 
in the treatment of acute myocardial infarction could explain only about 
five percent of the change in CHD mortality.10 However, similar to the other 
countries in which the IMPACT project was carried out, changes in all 
treatments could contribute to a 37 percent change in CHD mortality.11-15 
This could be an effect of the considerable increase in the use of cardio-
protective drugs (i.e., aspirin, beta-blockers, ACE-inhibitors, lipid-lowering 
and anti-diabetic agents) in secondary prevention, which was observed 
between  1997  and  2006.12,13  Findings  from  EUROASPIRE  III  surveys 
proved that, with the exception of statins, cardioprotective drugs (especially 
beta-blockers and ACE-inhibitors) were used more intensively in Poland 
than in many countries from West Europe. However, the frequency of use 
of cardioprotective drugs varied in the other CEE countries being generally 
lower than in West Europe.14 In conclusion, it is worthwhile to underscore 
the point that revascularization procedures and cardioprotective treatments 
remain important tools in the management of CHD, especially in the acute 
phase and after, but their potentials to control all CVD is limited. 422 PublicHealthReviews,Vol.33,No2
RISK FACTORS
Most of the decline in CVD mortality can be attributed to change in the 
incidence of the disease. In the WHO MONICA Project, coronary event 
rate contributed to 79 percent of the average decline in CHD mortality in 
men and to 65 percent in women.4 Both incidence and mortality are related 
to  the  exposure  to  modifiable  CVD  risk  factors  such  as  smoking,  low 
physical  activity,  hypertension,  dyslipidemia,  unfavourable  diet,  obesity 
and diabetes.15 In the INTERHEART Study, potentially modifiable risk 
factors accounted for over 90 percent of the risk of an initial acute myocardial 
infarction.16 Earlier findings from The WHO MONICA Project confirmed 
that ten-year trends in CHD were partly explained by changes in classic risk 
factors.17 Changes in mortality trends may also be explained by the changes 
in health-related behaviours such as fruit and vegetable consumption, fat 
intake or physical activity, which were not subjected to core MONICA 
observations. Ecological analysis done in Poland in the 1990s suggested 
that falling CHD mortality coincided with the decreasing consumption of 
butter and increasing consumption of vegetable oils and “exotic” fruits.18 
Fig.  5.  Changes  in  smoking  in  six  East  and  Central  European  countries  and 
European Union (15 countries before May 2004)
Source: WHO Europe, European HFA Database, December 2011.3
Figures 5-7 show percent change in smoking, consumption of fruits and 
vegetables and changes in proportion of energy from fats in the same CEE 
countries for which mortality trends were presented earlier in Figure 3. 
Changes in proportion of smokers, which are reflected by trends in CVD 
mortality  in  Poland,  Czech  Republic  and  Estonia  support  the  smoking 
reduction hypothesis. Increase in smoking rates in Estonia occurred at the 
same time as an increase in CVD mortality in the early 1990s, and a decrease CardiovascularDiseaseinCentralandEastEurope 423
in smoking rates was followed by the decrease in CVD mortality rates in all 
three countries. In Poland, since 1990, there was a systematic reduction in 
the proportion of smokers and despite a small fluctuation in 2005, per cent of 
smokers in 2009 was about 30 percent lower than in 1993. In the Czech 
Republic, a steady decline in smoking rates between 1993 and 2002 was 
observed and then after short increase in 2003, a systematic decrease was 
observed again. Finally, in 2009 in the Czech Republic the smoking rate was 
approximately ten percent lower compared to the baseline estimate in 1993. 
In Russia, there was a fairly stabile increase in smoking rate, which finally 
resulted in a 20 percent increase in the period from 1991 to 2004. This could 
contribute to the increase in CVD mortality but did not explain the decrease 
in the mid-1990s. The relationship between the proportion of smokers and 
CVD mortality in Latvia was even less clear as fluctuations between 1994 
and 2002 were not reflected by changes in CVD mortality, but a later decrease 
in smoking rate coincided with a fall in the mortality rate. In Ukraine, there 
has been a fairly stable decline in the proportion of smokers since 1990 with 
a rising trend in CVD mortality, until 2004, when the trend reversed.
Fig.  6.  Changes  in  fruits  and  vegetables  consumption  in  six  East  and  Central 
European countries and European Union (15 countries before May 2004). 
Source: WHO Europe, European HFA Database, December 2011.3
Fig. 7. Changes in proportion of energy from fats in six East and Central European 
countries and European Union (15 countries before May 2004).
Source: WHO Europe, European HFA Database, December 2011.3424 PublicHealthReviews,Vol.33,No2
In  general,  in  CEE  countries  consumption  of  fruits  and  vegetables 
increased after 1991. The most pronounced increase was observed in Latvia 
and Estonia and after 1999 in Russia and Ukraine. However, in the latter 
countries changes in fruits and vegetables consumption was too limited to 
explain fluctuations in CVD mortality. In Poland and in the Czech Republic, 
the  increase  in  fruits  and  vegetables  intake  was  smaller  because  the 
consumption was already higher at baseline. Changes in these countries did 
not exceed 25 percent (within the same period consumption doubled in 
Estonia), which could have had less impact on CVD mortality. 
Relations  between  trends  of  fat  intake  and  CVD  mortality  are  not 
striking  because  of  strong  irregular  fluctuations  in  some  countries  and 
stabile consumption in others. For example, in Poland, like in the EU15 
countries, consumption of energy from fats remained at the same level 
since 1990 (there is an evidence mentioned earlier that composition of 
consumed fats improved22). In the Czech Republic there was even a 15 
percent increase in consumption of energy from fats at the time when CVD 
mortality continued to decrease. 
According to WHO data from 2002 and projections for 2005 and 2010, 
exposure to CVD risk factors such as hypertension, elevated cholesterol 
level or obesity in CEE countries was not higher than in Western Europe.1 
Mean systolic blood pressure in CEE countries was between 124 mmHg 
and 129 mmHg, mean total cholesterol was between 4.9 mmol/l and 5.5 
mmol/l, and mean body mass index between 24.3 kg/m2 and 26 kg/m2. All 
these values were within the range observed in the western EU countries 
from before the enlargement in 2004 (Figure 8).
After the MONICA study period (1982-1994), evidence from the large 
population  studies  based  on  standardized  methods  of  data  collection  is 
scarce. One of the few examples is the national survey carried out in Poland 
in 2003-2004. This study showed that control of hypertension and dys-
lipidemias was definitely below expectations, which was mainly due to a 
combined effect of poor population awareness and poor compliance with 
medication.19,20 Further, the effectiveness of national prevention programs 
introduced later was lower than expected.21 However, secondary prevention 
medical care seems to be more effective. In the EUROASPIRE III study, in 
CEE countries, the proportions of persons who reached the LDL-cholesterol 
treatment target were slightly lower than in West Europe, which reflected 
less frequent use of statins. Some other risk factors (e.g., hypertension, 
overweight, diabetes) were controlled to a similar extent as in the other EU 
countries  or  even  better. Also,  the  proportion  of  patients  who  attended 
cardiac rehabilitation program was no worse in the CEE countries. However, 
lifestyle after an event was generally less favourable. For example, out of six 
countries with the highest rate of persistent smoking five were from CEE.18CardiovascularDiseaseinCentralandEastEurope 425
Fig. 8. Exposure to CVD risk factors in six Central and Eastern Europe countries 
compared to the highest and the lowest values in EU (15 countries before May 
2004). 
Source: Allender S, Scarborough P, Peto V, Rayner M. European CVD statistics 2008 
edition, British Heart Foundation, 2008.1426 PublicHealthReviews,Vol.33,No2
Results from the project IMPACT, which aimed to explain determinants 
of the decline in CHD mortality in Poland between 1991 and 2005, suggested 
that 52 percent of the decrease in men and 60 percent in women could be 
explained by favourable changes in the exposure to risk factors - mainly to 
hypercholesterolemia and low physical activity in both sexes, smoking in 
men and hypertension in women.7 However, earlier study done in Poland did 
not confirm that change in risk factors was a triggering factor for the dynamic 
reversal of the trend in 1991. At that time, changes in risk factors in Poland 
were small and diverse and little explained changes in CHD mortality.22 
Changes in major risk factors that occurred in CEE countries must have had 
an important impact on CVD mortality, but available data from routine 
statistics do not confirm that they were the predominant determinants of the 
trends and especially that changes in risk factors were the main triggering 
factor for the decline in CVD mortality in all CEE countries. 
ALCOHOL HYPOTHESIS 
High consumption of alcohol is related to cardiovascular risk independent 
of classic CVD risk factors and, in addition to the volume consumed, it has 
been suggested that the pattern of drinking is also important.19,23,24 There is 
evidence that episodic consumption of high amounts of alcohol (binge 
drinking) is associated with high risk of coronary heart disease,25 stroke26 
and metabolic syndrome.27 The effect of alcohol consumption on cardio-
vascular risk is strengthened by the increase of blood pressure in drinkers.28
Alcohol consumption was considered to be one of the main factors 
responsible for striking fluctuations in CVD mortality in the 1980s and mid-
1990s in Russia. After the decrease in alcohol consumption, which was the 
result  of  Gorbachev’s  anti-alcohol  campaign,  a  sharp  increase  in  life 
expectancy  in  Russia  was  observed.  The  decrease  in  CVD  mortality 
observed at that time was assumed to reflect an effect of reduced alcohol 
consumption.  Such  a  change  could  not  be  explained  by  other  known 
determinants of health.29 Also, stabile mortality from neoplasms, in contrast 
to CVD deaths and deaths from external causes at that time, confirmed that 
changes in mortality were not an artefact and could be alcohol related.30 It 
was suggested that the decrease and later increase in CVD mortality were 
related to the introduction of the anti-alcohol campaign in June 1985 and its 
later collapse. In 1992, mortality increased largely when hyperinflation 
began and alcohol prices were growing much slower than salaries. However, 
later findings from Russia and observations from other CEE countries do 
not confirm the alcohol hypothesis. Recent data showed that, when the CardiovascularDiseaseinCentralandEastEurope 427
CVD mortality had started to decrease in 2004, alcohol consumption was 
still increasing in Russia. In contrast to Russia, in Ukraine and Estonia, a 
dynamic decrease in alcohol consumption was reported in the early 1990s, 
which coincided with increasing CVD mortality. In these two countries, the 
falling trend in CVD mortality was later observed to coincide with increasing 
alcohol consumption. Increasing alcohol consumption was also observed in 
the other CEE countries in which a decreasing CVD mortality trend was 
observed, including Latvia in which changes in alcohol con  sumption and 
CVD mortality were similar to Russia at the beginning of 1990s (Figure 9). 
Fig. 9. Pure alcohol consumption in six Central and Eastern European countries and 
European Union (15 countries before May 2004).
Source: WHO Europe, European HFA Database, December 2011.3
Routine statistics indicate that, with the exception of Czech Republic, 
alcohol consumption is lower in CEE than in other EU countries.3 The type 
of consumption could however contribute to more harmful health effects of 
alcohol consumption in CEE countries, which are known to practice binge 
drinking. According to the results of the prospective study of the Russian 
population of Novosibirsk, increased risk of cardiovascular death was found 
only in frequent heavy drinkers (RR=2.05; 95%CI=1.09-3.86),31 so the risk 
of CVD death would be higher only in people drinking more than 120g of 
pure alcohol per occasion and more often than three times a week. Such 
drinking patterns were found only in five percent of the study group. It is 
unlikely that the size of that group increased sufficiently to cause a large 
change in the whole country mortality figures. In another Russian study by 
Deev et al., no differences in CVD mortality were found between drinkers 
and non-drinkers.32 Evidence based on the observation of the mortality and 
alcohol  consumption  trends  in  Russia,  their  plausibility  and  biological 
mechanisms are debated still.33,34 Nevertheless, it is unlikely that alcohol 
consumption could fully explain CVD mortality trends in CEE countries 
and the differences in mortality rates between Eastern and Western Europe. 428 PublicHealthReviews,Vol.33,No2
ECONOMIC AND PSYCHOSOCIAL FACTORS
There were two interesting time points in the history of CVD in CEE. The 
first at the beginning of the 1990s, when CVD mortality started to decrease 
dynamically in the Czech Republic, Hungary and Poland continuing until 
the present. At the same time in the other CEE countries, CVD mortality 
continued  to  increase  and  most  countries  of  the  former  Soviet  Union, 
particularly  Russia,  experienced  an  unprecedented  increase  in  CVD 
mortality in the years 1992-1994. The second interesting time point was in 
the year 1998, in which the second rise in CVD mortality was observed in 
Russia and in some other former Soviet Union countries while in Baltic 
countries CVD mortality continued to decrease as in the Czech Republic, 
Hungary and Poland. 
Fig. 10. Relationship between GDP per capita and CVD mortality in European 
Union and three not EU Eastern European countries (last available year). 
Source: WHO Europe, European HFA Database, December 2011.3
There is a clear relation between wealth and CVD mortality in Europe. 
The relation between GDP per capita and CVD mortality is striking (Figure 
10).  The  Russian  case  supports  the  hypothesis  that  rapid  increases  in 
mortality seem to coincide with major economic instability. Stuckler et al. 
pointed out the importance of mass privatization in Russia, which caused 
unemployment and job instability.35,36 It is worth however, to add that the 
effect of privatization was strengthened by the 1992 Rouble crisis, which 
was  followed  by  the  collapse  of  the  pension  system  and  the  spread  of 
poverty.  Stuckler  et  al.  compared  mortality  trends  between  Russia  and CardiovascularDiseaseinCentralandEastEurope 429
Belarus in which transformation to market economy was very limited and 
privatization of industry was halted quickly. This could not recover the 
country  economy  but  limited  destabilization.  Belarus,  in  which  CVD 
mortality trend was parallel to Russia before 1990, avoided the steep increase 
in mortality in the next years.40 However, mass privatization was not only the 
case in Russia. Rapid, mass privatization also started in Poland in 1990. 
Unemployment increased from less than one percent in 1990 to 16 percent 
in 1994.37 Similar to Russia, privatization was introduced at the same time 
as a severe financial crisis. In 1990, inflation of Polish Złoty reached nearly 
600 percent and it was 70 percent, 43 percent and 35 percent in the next 
three  years  respectively.38  In  contrast  to  Russia,  at  the  time  of  mass 
privatization and currency crisis, Poland experienced a dynamic decrease of 
CVD mortality (Figure 11). The main difference was that in Poland both 
political transformation and a shift to market economy were welcomed by 
the public. Also the Czech Republic and Hungary, in which political and 
economic transformation were accepted by the society, followed the same 
mortality pattern. In Russia and in the other countries of the former Soviet 
Union, political reforms and economic transformation were rather shocking 
for the society. The coincidence of the second rise in CVD mortality with 
the  1998  Rouble  crisis  in  Russia  and  some  other  former  Soviet  Union 
countries would confirm the link between economic instability and CVD 
and it is less surprising that a rise in CVD mortality rates was not observed 
in former Soviet Union Baltic countries, which at that time introduced 
economic reforms to allow for their accession to the EU. Comparison of the 
coincidence  of  changes  in  CVD  mortality  with  the  economic  crises  in 
Poland and in Russia suggest that objective measures of economic instability 
on the population level are not as important as its perception in the society.
Fig. 11. CVD mortality in Russia and Poland. 
Source: WHO Europe, European HFA Database, December 2011.3430 PublicHealthReviews,Vol.33,No2
For  individual  people,  economic  instability  causes  threats  that  are 
beyond their control, threats to the social status, respect or acceptance in 
the group, and to self-worth, which are typical for psychosocial stress. 
Evidence for the association between chronic psychosocial stress and CVD 
is accumulating. Such traits as depression, anxiety, low social position, low 
control over one’s own life and health, poor job conditions (effort-reward 
imbalance,  job  strain)  are  recognized  as  important  psychosocial  risk 
factors.19 The evidence from CEE countries is scarce, but the clear relation 
between education and CVD mortality, which was confirmed in almost all 
CEE  countries39-45  seems  to  support  that  CVD  risk  is  higher  among 
disadvantaged  groups  just  as  it  is  in  Western  Europe.  There  is  also 
confirming evidence that unfavourable working conditions are related to 
depression and worse health.40,41
The  hypothesis  that  dynamic  changes  in  CVD  mortality  in  CEE 
countries are explained by psychosocial factors is attractive, but there is no 
firm evidence to confirm it. In the INTERHEART Study adverse psycho-
social conditions were associated with an increased risk of myocardial 
infarction and contributed to 35 percent of the population attributable risk.42 
However, current knowledge does not allow for a quantitative estimate of 
to what extent differences in the exposure to psychosocial factors explain 
the variation in CVD mortality between the European countries and the life 
expectancy gap between East and West Europe.
The relationship between CVD and psychosocial stress was recognized 
by European scientific societies. However, the present recommendations 
for clinical practice are limited to the assessment of main psychosocial risk 
factors followed by intensive intervention on classic risk factors in high risk 
individuals; no direct intervention to lower exposure to psychosocial stress 
is postulated.16 Nevertheless, accumulating knowledge allowed the WHO 
Commission on Social Determinants of Health to propose three principles 
of  action:  1)  improve  the  condition  of  daily  life,  2)  tackle  inequitable 
distribution of power, money and resources, 3) measure and understand the 
problem and assess the impact of action.43 It is obvious that the nature of 
the latter recommendations requires attention from beyond the medical and 
public health system to - politicians, economists and other structural drivers 
of daily life. The strategy of intervention seems to be encompassed for the 
future, but what priority will be assigned to it in CEE in the time of the 
current economic crisis in the world remains an open question. CardiovascularDiseaseinCentralandEastEurope 431
CONCLUSIONS
CVD  is  the  most  important  cause  of  mortality  in  CEE  countries  and 
contributes  largely  to  the  life  expectancy  gap  between  East  and  West 
Europe.  Rapid  development  of  high  technology  treatment  procedures, 
which followed the economic recovery of the CEE countries would have 
only limited influence on the overall control of CVD. Exposure to classic 
risk factors might explain to a large extent the longitudinal trend in falling 
CVD mortality in some countries but it is unlikely that it could explain 
rapid changes in the others. Still, large potential to control the disease lies 
in developing effective preventive policies with targets to lower exposure to 
the classic CVD risk factors. There is no doubt about the beneficial health 
effect of controlling alcohol consumption but the recent history of CVD in 
CEE  countries  made  the  “alcohol  hypothesis”  less  convincing  as  an 
explanation for CVD mortality trends and differences between East and 
West Europe. The hypothesis that dynamic changes in CVD mortality in 
CEE countries are triggered and explained largely by psychosocial factors 
is attractive. However, if confirmed, transforming such knowledge into a 
practical health policy would be a great challenge.
Acronyms list:
CEE = Central and East European countries
CHD = Coronary Heart Disease
CVD = Cardiovascular Disease
EU15 = The 15 EU member states prior to 2004
WHO  MONICA  =  Multinational  MONItoring  of  trends  and  determinants  of 
CArdiovascular disease
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